Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus

NCT: NCT07070089 · RECRUITING

NCT IDNCT07070089
StatusRECRUITING
Start Date2026-02-01
Completion2028-07

Brief Summary

This study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity of pulse-synchronous tinnitus.

Frequently Asked Questions

What is BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus?

BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus is a clinical trial registered under NCT07070089. Current status: RECRUITING.

What is the status of NCT07070089?

The current status of NCT07070089 (BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus) is: RECRUITING.

When did BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus start?

BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus started on 2026-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑